TABLE OF CONTENTS
1 INTRODUCTION 10
1.1 OBJECTIVES OF THE STUDY 10
1.2 MARKET DEFINITION 10
1.3 OVERVIEW OF U.S. HEALTHCARE ANALYTICS MARKET 11
1.4 CURRENCY AND PRICING 12
1.5 LIMITATION 12
1.6 MARKETS COVERED 12
2 MARKET SEGMENTATION 14
2.1 MARKETS COVERED 14
2.2 YEARS CONSIDERED FOR THE STUDY 15
2.3 CURRENCY AND PRICING 15
2.4 RESEARCH METHODOLOGY 16
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 19
2.6 SECONDARY SOURCES 20
2.7 ASSUMPTIONS 20
3 EXECUTIVE SUMMARY 21
4 PREMIUM INSIGHTS 24
5 MARKET OVERVIEW 26
5.1 DRIVERS 28
5.1.1 GOVERNMENT INITATIVES TO ENCOURAGE USE OF ELECTRONIC HEALTH RECORDS 28
5.1.2 INTRODUCTION OF NEW SOLUTIONS AND SERVICES IN HEALTHCARE ANALYTICS 29
5.1.3 ENTRY OF BIG DATA INTO HEALTHCARE 29
5.1.4 GROWING NEED TO CURB HEALTHCARE SPENDING WITH BETTER CLINICAL OUTCOMES 30
5.2 RESTRAINT 30
5.2.1 LESS NUMBER OF SKILLED PERSONNEL 30
5.3 OPPORTUNITIES 31
5.3.1 GROWING AWARENESS ABOUT ANALYTICS IN VALUE AND PRECISION BASED CARE 31
5.3.2 INCREASE IN CLOUD BASED ANALYTICS 31
5.3.3 INCREASING IMPACT ON HEALTHCARE INDUSTRY DUE TO SOCIAL MEDIA 32
5.3.4 RISING PATIENT REGISTRIES 32
5.4 CHALLENGES 33
5.4.1 DATA CONFIDENTIALITY 33
5.4.2 ISSUES IN DATA ACCURACY AND CONSISTENCY 33
5.4.3 DATA INTEGRATION 34
5.4.4 FUNCTIONING GAP BETWEEN THE PROVIDERS AND PAYERS 34
6 U.S. HEALTHCARE ANALYTICS MARKET, BY TYPE 35
6.1 OVERVIEW 36
6.2 PRESCRIPTIVE ANALYTICS 37
6.3 PREDICTIVE ANALYTICS 37
6.4 DESCRIPTIVE ANALYTICS 37
7 U.S. HEALTHCARE ANALYTICS MARKET, BY COMPONENT 38
7.1 OVERVIEW 39
7.2 SERVICES 41
7.2.1 SUPPORT SERVICES 41
7.2.2 BUSINESS ANALYTICS SERVICES 41
7.3 SOFTWARE 42
7.4 HARDWARE 42
8 U.S. HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODEL 43
8.1 OVERVIEW 44
8.2 ON-DEMAND 45
8.3 ON-PREMISE 45
9 U.S. HEALTHCARE ANALYTICS MARKET, BY APPLICATION 46
9.1 OVERVIEW 47
9.2 CLINICAL ANALYTICS 48
9.2.1 REGULATORY REPORTING AND COMPLIANCE 49
9.2.2 QUALITY IMPROVEMENT AND CLINICAL BENCHMARKING 49
9.2.3 CLINICAL DECISION SUPPORT 49
9.2.4 COMPARATIVE ANALYTICS/ EFFECTIVENESS 49
9.2.5 PRECISION HEALTH 49
9.3 POPULATION HEALTH ANALYTICS 50
9.3.1 POPULATION CARE MANAGEMENT 50
9.3.2 POPULATION RISK MANAGEMENT 50
9.3.3 PATIENT ENGAGEMENT 50
9.3.4 CLINICAL OUTCOME MANAGEMENT 50
9.3.5 ACTIVITY-BASED COSTING 50
9.4 FINANCIAL ANALYTICS 51
9.4.1 PAYMENT INTEGRITY AND FRAUD, WASTE, AND ABUSE (FWA) 51
9.4.2 REVENUE CYCLE MANAGEMENT (RCM) 51
9.4.3 RISK ADJUSTMENT AND RISK ASSESSMENT 51
9.4.4 CLAIMS PROCESSING 51
?
9.5 OPERATIONAL AND ADMINISTRATIVE ANALYTICS 52
9.5.1 SUPPLY CHAIN ANALYTICS 52
9.5.2 WORKFORCE ANALYTICS 52
9.5.3 RESEARCH ANALYTICS 52
9.5.4 MARKET INTELLIGENCE 52
9.5.5 ENTERPRISE PERFORMANCE 53
9.5.6 STRATEGIC ANALYTICS 53
10 U.S. HEALTHCARE ANALYTICS MARKET, BY END USER 54
10.1 OVERVIEW 55
10.2 HEALTHCARE PAYERS 56
10.2.1 GOVERNMENT AGENCIES 56
10.2.2 PRIVATE INSURANCE COMPANIES 56
10.2.3 EMPLOYERS AND PRIVATE EXCHANGES 57
10.3 HEALTHCARE PROVIDERS 57
10.3.1 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS 57
10.3.2 AMBULATORY SETTINGS 57
10.3.3 POST-ACUTE CARE ORGANIZATIONS 57
10.4 ACOS, HIES, MCOS AND TPAS 57
11 U.S. HEALTHCARE ANALYTICS MARKET, COMPANY LANDSCAPE 58
11.1 COMPANY SHARE ANALYSIS; U.S. 58
12 COMPANY PROFILES 59
12.1 ALLSCRIPTS 59
12.1.1 COMPANY OVERVIEW 59
12.1.2 REVENUE ANALYSIS 59
12.1.3 PRODUCT PORTFOLIO 60
12.1.4 RECENT DEVELOPMENTS 62
12.2 OPTUM INC. 63
12.2.1 COMPANY OVERVIEW 63
12.2.2 GEOGRAPHICAL PRESENCE 63
12.2.3 PRODUCT PORTFOLIO 64
12.2.4 RECENT DEVELOPMENTS 68
12.3 ORACLE 69
12.3.1 COMPANY OVERVIEW 69
12.3.2 REVENUE ANALYSIS 69
12.3.3 PRODUCT PORTFOLIO 70
12.3.4 RECENT DEVELOPMENTS 70
?
12.4 CERNER 71
12.4.1 COMPANY OVERVIEW 71
12.4.2 REVENUE ANALYSIS 71
12.4.3 PRODUCT PORTFOLIO 72
12.4.4 RECENT DEVELOPMENTS 76
12.5 CITIUSTECH INC. 77
12.5.1 COMPANY OVERVIEW 77
12.5.2 GEOGRAPHICAL PRESENCE 77
12.5.3 PRODUCT PORTFOLIO 78
12.5.4 RECENT DEVELOPMENTS 78
12.6 WIPRO LIMITED 79
12.6.1 COMPANY SNAPSHOT 79
12.6.2 REVENUE ANALYSIS 79
12.6.3 PRODUCT PORTFOLIO 80
12.6.4 RECENT DEVELOPMENTS 80
12.7 VITREOSHEALTH 81
12.7.1 COMPANY SNAPSHOT 81
12.7.2 GEOGRAPHICAL PRESENCE 81
12.7.3 PRODUCT PORTFOLIO 82
12.7.4 RECENT DEVELOPMENTS 82
12.8 SCIO HEALTH ANALYTICS 83
12.8.1 COMPANY SNAPSHOT 83
12.8.2 GLOBAL PRESENCE 83
12.8.3 PRODUCT PORTFOLIO 84
12.8.4 RECENT DEVELOPMENTS 84
12.9 HEALTHCARE CATALYST 86
12.9.1 COMPANY SNAPSHOT 86
12.9.2 GEOGRAPHICAL PRESENCE 86
12.9.3 PRODUCT PORTFOLIO 87
12.9.4 RECENT DEVELOPMENTS 89
12.10 GE HEALTHCARE 90
12.10.1 COMPANY SNAPSHOT 90
12.10.2 REVENUE ANALYSIS 90
12.10.3 PRODUCT PORTFOLIO 91
12.10.4 RECENT DEVELOPMENTS 92
12.11 IBM 93
12.11.1 COMPANY OVERVIEW 93
12.11.2 REVENUE ANALYSIS 93
12.11.3 PRODUCT PORTFOLIO 94
12.11.4 RECENT DEVELOPMENTS 94
12.12 INOVALON 95
12.12.1 COMPANY OVERVIEW 95
12.12.2 REVENUE ANALYSIS 95
12.12.3 PRODUCT PORTFOLIO 96
12.12.4 RECENT DEVELOPMENTS 97
12.13 VERSCEND TECHNOLOGIES INC. 98
12.13.1 COMPANY OVERVIEW 98
12.13.2 GEOGRAPHIC PRESENCE 98
12.13.3 PRODUCT PORTFOLIO 99
12.13.4 RECENT DEVELOPMENTS 100
12.14 1MCKESSON CORPORATION 101
12.14.1 COMPANY SNAPSHOT 101
12.14.2 2REVENUE ANALYSIS 101
12.14.3 PRODUCT PORTFOLIO 102
12.14.4 RECENT DEVELOPMENTS 103
12.15 SAS INSTITUTE 104
12.15.1 COMPANY OVERVIEW 104
12.15.2 REVENUE ANALYSIS 104
12.15.3 PRODUCT PORTFOLIO 105
12.15.4 RECENT DEVELOPMENTS 107
12.16 IKON-TECH 108
12.16.1 COMPANY OVERVIEW 108
12.16.2 PRODUCT PORTFOLIO 108
12.16.3 RECENT DEVELOPMENTS 108
12.17 IQVIA 109
12.17.1 COMPANY SNAPSHOT 109
12.17.2 REVENUE ANALYSIS 109
12.17.3 PRODUCT PORTFOLIO 110
12.17.4 RECENT DEVELOPMENTS 111
13 RELATED REPORTS 112